Annals of Oncology

In this issue:

In this issue
Ann Oncol 4: 439.
[PDF] [Request Permissions]

Contents of the next issue:

Contents of the next issue
Ann Oncol 4: 439.
[PDF] [Request Permissions]

News:

Europa Donna to set pressure even with more moderate charter
Ann Oncol 4: 440.
[PDF] [Request Permissions]

Funds for cancer research hit differently throughout Europe
Ann Oncol 4: 440.
[PDF] [Request Permissions]

San Salvatore Prize coupled with Kaplan Lecture goes to Gianni Bonadonna
Ann Oncol 4: 440-441.
[PDF] [Request Permissions]

European drug agency expected to impact on oncology
Ann Oncol 4: 441.
[PDF] [Request Permissions]

ICI to be split, Zeneca hires Workman
Ann Oncol 4: 441-442.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 4: 442.
[PDF] [Request Permissions]

Editorial:

Stanley B. Kaye

Antiemetic therapy — Where do we go from here?
Ann Oncol 4: 443-445.
[PDF] [Request Permissions]

Book reviews:

A. Goldhirsch

Book review
Ann Oncol 4: 445.
[PDF] [Request Permissions]

B. Miazza and G. Martinelli

Book review
Ann Oncol 4: 462.
[PDF] [Request Permissions]

Cristiana Sessa

Book review
Ann Oncol 4: 479.
[PDF] [Request Permissions]

Alberto Mantovani

Book review
Ann Oncol 4: 522.
[PDF] [Request Permissions]

Special articles:

H. M. Dupuis

Euthanasia in The Netherlands: Facts and moral arguments
Ann Oncol 4: 447-450.
[Abstract] [PDF] [Request Permissions]

Review:

W. Stadler and N. J. Vogelzang

Human renal cancer carcinogenesis: A review of recent advances
Ann Oncol 4: 451-462.
[PDF] [Request Permissions]

Commentaries:

L. Gianni

The relevance of pharmacology in clinical oncology practice: Pharmocology is relevant
Ann Oncol 4: 463-465.
[PDF] [Request Permissions]

J.G. McVie

The relevance of pharmacology in clinical oncology practice: Pharmacology is (as yet) not relevant...
Ann Oncol 4: 465.
[PDF] [Request Permissions]

P. Workman

The relevance of pharmacology in clinical oncology practice: The moderator thinks that...
Ann Oncol 4: 466-469.
[PDF] [Request Permissions]

Arena:

Y. Merrouche, G. Catimel, and M. Clavel

Hematopoietic growth factors and chemoprotectants: Should we move toward a two-step process for phase I clinical trials in oncology?
Ann Oncol 4: 471-474.
[PDF] [Request Permissions]

Original articles:

K. S. Buser, R. A. Joss, D. Piquet, M. S. Aapro, F. Cavalli, J. M. Haefliger, W. F. Jungi, J. Bauer, R. Obrist, K. W. Brunner, T. Weber, L. Verity, and M. Butcher

Oral ondansetron in the prophylaxis of nausea and vomiting induced by cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in women with breast cancer. Results of a prospective, randomized, double-blind, placebo-controlled study
Ann Oncol 4: 475-479.
[Abstract] [PDF] [Request Permissions]

V. Kirchner, M. Aapro, P. Alberto, P. O'Grady, B. Busch, and M. Boyce

Early clinical trial of MDL 73.147 EF: A new 5-HT₃-receptors antagonist for the prevention of chemotherapy-induced nausea and vomiting
Ann Oncol 4: 481-484.
[Abstract] [PDF] [Request Permissions]

T. A. Filtenborg, H. H. Hansen, S. Aage Engelholm, and M. Rrøth

A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix
Ann Oncol 4: 485-488.
[Abstract] [PDF] [Request Permissions]

M. Colleoni, E. Bajetta, P. Nelli, L. Boni, A. M. Bochicchio, F. Nolè, R. Buzzoni, L. Celio, V. Mazzaferro, G. Bonfanti, P. Bignami, and L. Gennari

Prognostic factors in patients affected by hepatocellular carcinoma treated with systemic chemotherapy: The experience of the National Cancer Institute of Milan
Ann Oncol 4: 489-493.
[Abstract] [PDF] [Request Permissions]

D. Zaridze, T. Evstifeeva, M. Babaeva, and P. Boyle

Fats used in seasoning and breast cancer risk: A case-control study in Moscow, Russia
Ann Oncol 4: 495-498.
[Abstract] [PDF] [Request Permissions]

M. Z. Khan, R. I. Freshney, A. M. McNicol, and A. M. B. Murray

Induction of phenotypic changes in SCLC cell lines in vitro by hexamethylene bisacetamide, sodium butyrate, and cyclic AMP
Ann Oncol 4: 499-507.
[Abstract] [PDF] [Request Permissions]

Clinical case:

G. F. McLeay and W. P. Steward

High grade soft tissue sarcoma
Ann Oncol 4: 509-514.
[PDF] [Request Permissions]

Short reports:

K. Pittman, T. Perren, U. Ward, J. Primrose, M. Slevin, N. Patel, and P. Selby

Pharmacokinetics of 5-fluorouracil in colorectal cancer patients receiving interferon
Ann Oncol 4: 515-516.
[Abstract] [PDF] [Request Permissions]

M. Marzola, M. Zucchetti, N. Colombo, C. Sessa, O. Pagani, M. D'Incalci, F. Cavalli, and C. Mangioni

Low-dose oral etoposide in epithelial cancer of the ovary
Ann Oncol 4: 517-519.
[Abstract] [PDF] [Request Permissions]

Letters:

D. Osoba and J. Pater

Letters to the editor: Assessing quality of life in clinical trials
Ann Oncol 4: 520.
[PDF] [Request Permissions]

C. Hürny

Letters to the editor: The above letter was referred to the authors, who respond as follows:
Ann Oncol 4: 520.
[PDF] [Request Permissions]

C. Bokemeyer, M. Lüer, H. -J. Schmoll, M. Freund, and H. Poliwoda

Letters to the editor: Secondary cancer following Hodgkin's disease
Ann Oncol 4: 520-521.
[PDF] [Request Permissions]

P. Foa, A. Iurlo, and A. T. Maiolo

Letters to the editor: Renal cancer after busulphan treatment for chronic myeloid leukemia: Therapeutic implications
Ann Oncol 4: 521-522.
[PDF] [Request Permissions]

Advertisements in this Issue:

R. B. Sim

Activators and inhibitors of Complement
Ann Oncol 4: 523.
[PDF] [Request Permissions]

Classfied advertisements from ESMO-members and meeting announcements
Ann Oncol 4: 524.
[PDF] [Request Permissions]

Bristol-Myers Squibb
Ann Oncol 4: 525.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.